Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

54.07%

54.05%

64.90%

Annual Dental Visits (ADV) Total

69.08%

45.09%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

33.26%

41.93%

46.74%

Appropriate Testing for Pharyngitis (CWP)

73.91%

67.15%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

93.00%

91.55%

93.08%

Asthma Medication Ratio (AMR) Total

58.26%

57.77%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

40.49%

57.95%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

64.48%

49.15%

68.61%

Breast Cancer Screening (BCS)

57.96%

64.93%

55.25%

Cervical Cancer Screening (CCS)

63.75%

69.10%

59.85%

Childhood Immunization Status (CIS) Combination #10

35.04%

39.17%

35.04%

Chlamydia Screening in Women (CHL) Total

69.92%

75.78%

61.07%

Controlling High Blood Pressure (CBP)

62.29%

53.77%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

73.16%

76.64%

80.86%

Eye Exam for Patients With Diabetes (EED)

56.69%

60.83%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

15.17%

19.68%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

39.39%

36.18%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

46.77%

45.76%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

39.10%

35.60%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD)

Continuation and Maintenance Phase

56.94%

55.66%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

46.47%

39.42%

55.72%

Immunizations for Adolescents (IMA) Combination #2

37.71%

45.26%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

13.70%

14.79%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

37.75%

42.16%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

28.29%

39.70%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

32.79%

39.16%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

78.57%

69.58%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

81.55%

85.17%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

77.50%

65.45%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

82.00%

82.97%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

69.34%

79.81%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

24.34%

25.84%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

4.61%

3.83%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

84.08%

81.00%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

64.20%

63.48%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

71.79%

69.08%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

58.82%

55.03%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

72.22%

70.56%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

73.26%

75.15%

75.44%

Use of Opioids at High Dosage (HDO)

2.12%

2.42%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

0.34%

0.54%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

82.73%

81.27%

83.21%